Himalaya Rumalaya Forte
Benefits of Rumalaya Forte: Relief from arthritis pain, joint stiffness, back pain, sciatica, spondylosis, Gout and other inflammatory conditions 
|
|
|
Rumalaya forte from Himalaya Herbals is a powerful herbal ayurvedic formulation. Rumalaya forte helps rebuild connective tissue and alleviates the discomfort caused by weaken movement. Arthritis and joint pain discomfort is a extensive occurrence that can result from such factors as climate, lifestyle, work habits, or repetitive movement. Taken every day, Rumalaya forte has recognized positive results in relieving pain due to a variety of conditions, including arthritis, osteoarthritis, back pain, frozen shoulder and other joint conditions. Rumalaya forte is an proficient anti-inflammatory analgesic with immunomodulatory action. Rumalaya forte is mainly formulated for long-term use in arthritis and other painful inflammatory disorders affecting muscles and joints. Rumalaya forte is an unbeaten and safe alternative to other anti-inflammatory drugs. Rumalaya forte is a potent herbomineral formulation with the dual advantage of Shallaki and Guggulu. Rumalaya forte provides improved arthritis control, and thus improves the quality of life in arthritic patients.
Shallaki and Guggulu are well known in medical and scientific communities that across the world for their proven efficacy in joint care. Shallaki (Boswellia serrata) present in Rumalaya forte is approved by the FDA and Council of Europe. Guduchi in Rumalaya forte is hewell known for its immunomodulatory activity. Rumalaya forte also contains Rasna, Yashti-madhu and Gokshura. Clinical trials have proven the effectiveness and safety of Rumalaya forte. Rumalaya forte exerts strong immunomodulatory, anti-inflammatory analgesic actions, and thereby reduces the joint swelling, relieves pain and improves joint mobility.
Indications for taking Rumalaya forte
Rumalaya Forte is helpful for treating
- Rheumatoid arthritis
- Osteoarthritis
- Cervical and lumbar spondylosis
- Traumatic inflammatory conditions like fibrositis, bursitis, synovitis, capsulitis, tenosynovitis, myositis and sciatica
- Arthralgia
- Gout
- Frozen shoulder
Benefits of Rumalaya forte
- Relieves pain from the arthritis and other traumatic inflammatory conditions
- Rumalaya forte helps to rebuild connective tissue
- Rumalaya forte is safe and non habit forming
Rumalaya forte is an effective and safe alternative to NAISDs as it has no side effects. NSAIDs are less than ideal as most of the NSAIDs are known to cause the gastric irritation, gastrointestinal ulceration, reduced renal blood flow, platelet dysfunction and exacerbation of asthma, allergic reactions and skin rashes. Hence, these drugs are not recommended for long-term administration. Rumalaya forte is particularly formulated for long-term use in arthritis and other painful inflammatory disorders since it is a herbo-mineral formula.
Rumalaya forte Ingredients (Per Tablet):
- Boswellia / Shallaki ( Boswellia serrata ) 240mg
- Indian Bedellium / Guggul ( Commiphora wightii ) 200mg
- Rasna ( Alpinia galanga ) 70mg
- Licorice / Yashti madhu ( Glycyrrhiza glabra ) 70mg
- Small caltrops / Gokshura ( Tribulus terrestris ) 60mg
- Tinospora Gulancha / Guduchi ( Tinospora cordifolia ) 60mg
Directions for taking Rumalaya forte
2 capsules twice on a daily basis with meals.
Rumalaya forte from Himalaya Herbals
Rumalaya forte is from the renowned Himalaya Herbals brand that endorsed by over 250,000 doctors worldwide and used by customers in over 60 countries. Himalaya Herbals products have been researched clinically and standardized to guarantee its bioequivalence. Bioequivalence refers to ensuring that the product on the market is equivalent to the one on which clinical trials were productively conducted. Himalaya Herbal Healthcare uses chromatographic fingerprinting, one of the most sophisticated standardization techniques, to ensure consistent quality and performance
Rumalaya forte Research and Clinical Studies
Rumalaya forte and Reosto in Osteoarthritis : A combined study
Dr. U.C. Nachinolcar, D.Orth. (Madras), M.S. (Bom.), Consultant Orthopedic Surgeon and
Dr. Prasad D.P. Salgaonkar, B.A.M.S., Medical Director Aravali Medical and Research Center Aravali, Vengurla Taluka, Sindhudurg District, Maharashtra-416 518, India
Dr. S.R. Prasad*, M.D., Medical Advisor
Dr. S.K. Mitra, M.D., Executive Director R&D Center The Himalaya Drug Company Makali, Bangalore-562 123 (India).
ABSTRACT
The study was carried out to establish the efficacy, tolerability and safety of Rumalaya forte and Reosto combination therapy in osteoarthritis and to evaluate the results with Rumalaya forte alone, both being polyherbal formulations. One hundred patients of either sex, between the ages of 40 to 70 years, fulfilling the American College of Rheumatology criteria for knee osteoarthritis and with clinical and radiological evidence of stage II and III osteoarthritis of knee joints along with involvement of other joints were included in the study and were divided into two groups on the basis of a computer generated random number allocation program. Group I received one tablet of Rumalaya forte and two tablets of Reosto, and Group II received in one tablet of Rumalaya forte and 2 tablets of placebo for a period of 6 months. Pain, function and stiffness were evaluate using WOMAC osteoarthritis index. Time taken to cover 10 meter distance, BMD score, VAS score and patient global assessment were assessed. The intention to treat the population consisted of hundred patients. Both groups showed significant improvement in clinical characteristics viz., WOMAC osteoarthritis index, joint stiffness score, joint function score, walking assessment, BMD score and VAS score (p<0.01). nevertheless, difference between response of overall intuition between the two groups was statistically significant (p<0.01), Group I performing significantly better than Group II. Absence of any adverse reaction and steady hematological and biochemical parameters till the completion of treatment recommended that the combination of Rumalaya forte and Reosto is safe for extended therapy and is well tolerated.
ABBREVIATIONS
BMD : Bone mineral density
COX : Cyclo-oxygenase
DEXA : Dual energy-X-ray absorptiometry
DPPH : Diphenyl picryl hydrazyl
IL : Interleukin
NF-Kappa-b : Nuclear factor kappa-beta
TNF-a : Tumor necrosis factor-alpha
VAS : Visual analog scale
WOMAC : Western Ontario and McMaster Universities
Evaluating the safety and efficacy of Rumalaya forte: A double-blind clinical trial
Rastogi, S., Additional Professor, Sivaraman, S.T., Senior Resident, Department of Orthopedics, All Indian Institute of Medical Sciences, New Delhi, India, and Kala Suhas Kulkarni, Medical Advisor, R&D Center, The Himalaya Drug Company, Bangalore, India.
ABSTRACT
A double-blind clinical study was conducted to evaluate the efficacy and safety of Rumalaya forte, a polyherbal formulation in the management of osteoarthritis. Fifty patients of either sex in the age group of 50-65 years with clinical and radiological evidence of osteoarthritis were selected for the trial. The patients were arbitrarily divided into two groups. Group A patients received Rumalaya forte at a dose of 1 tablet twice daily, and Group B received a placebo at the same dose. All symptom along with severity and duration were recorded preceding to the drug treatment. Routine blood chemistry and radiography were done at before and at the end of the treatment period. Patients were track up every 4 weeks for 6 months. At the end of 6 months symptomatic assessment was carried out to resolve the clinical efficacy of the trial drug. Results revealed that the average score for the number of joints involved before the treatment was 3.44 in Group A and 2.72 in Group B. The score was reduced from the 3.44 to 1.16 in Group A and from 2.72 to 1.47 in Group B. Thus, there was 66.28% reduction into the number of joint involvements in the Rumalaya forte-treated group and 51.94% in the placebo group. In subjective symptomatic evaluation, Group A had an average score of 18.56, which reduced to 8.02 indicating 45.96% relief in various symptoms. The subjective symptomatic score in Group B reduced from 19.63 to 13.92, indicating the 29.09% relief in various symptoms. Twenty of the 25 patients in Group A were satisfied with the drug and showed significant improvement in the symptoms and mobility. In Group B only few patients expressed their contentment to relief in pain. Patients those belonging to Group A therefore had major alleviation of symptoms in terms of relief of pain and free mobility of the joints. No side effects were reported by any of the patients.
Go to Products Page or Male Health or Female Health Section.
Testimonial
I have started using M2 Tone for past 2 months and I am 80 % fine now. God bless. Anna Braf, USA.
I used to weight 170 pounds 3 months back and now I weight 140 pounds and am still losing. Obeslim is the best weight loss pill I have ever seen in my life. I will recommend it to all the obese people especially young ones to use it and reduce weight . Celina Clive, Barbedos
Orgy . Has totally changed my life and its really hard to believe that how you have made it possible. It's really magic. Thank you very much herbalcureindia team. Good luck. Lee Chang, Japan.
I am satisfied with the usage of Shilajit Gold and Shilajit capsule and will surely recommend this my friends and relatives. Karifa Haroon, Dubai
Thanks a lot Dr. Smith, you have made my life. I had been suffering from acne from past 9 years and by using Skinelle they faded in 3 months and for past 2 months there has not been a single acne on my face and the scars have also lightened. I am very happy. MUUUUUhh..with lots of love and regards, Maggie, Texas. I am satisfied with your male products and would also like to order for my friend. Thanks. Niel, toranto
"I am using Ashwagandha amd Brahmi capsules for past 6 or 7 months now and I find it very superior for energy and minor stress related problems thanks a lot I would use more products" Noone, United States |
